Unit of Infection and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.
Turku Doctoral Programme of Molecular Medicine, University of Turku, Turku, Finland.
Cancer Res Commun. 2022 Nov 4;2(11):1344-1354. doi: 10.1158/2767-9764.CRC-22-0211. eCollection 2022 Nov.
Merkel cell carcinoma (MCC) is an aggressive skin cancer, which is frequently caused by Merkel cell polyomavirus (MCPyV). Mutations of MCPyV tumor (T) antigens are major pathologic events of virus-positive (MCPyV+) MCCs, but their source is unclear. Activation-induced cytidine deaminase (AID)/APOBEC family cytidine deaminases contribute to antiviral immunity by mutating viral genomes and are potential carcinogenic mutators. We studied the contribution of AID/APOBEC cytidine deaminases to MCPyV large T (LT) truncation events. The MCPyV area in MCCs was enriched with cytosine-targeting mutations, and a strong APOBEC3 mutation signature was observed in MCC sequences. and expression were detected in the Finnish MCC sample cohort, and expression correlated with and . Marginal but statistically significant somatic hypermutation targeting activity was detected in the MCPyV regulatory region. Our results suggest that APOBEC3 cytidine deaminases are a plausible cause of the truncating mutations in MCPyV+ MCC, while the role of AID in MCC carcinogenesis is unlikely.
We uncover APOBEC3 mutation signature in MCPyV that reveals the likely cause of mutations underlying MCPyV+ MCC. We further reveal an expression pattern of APOBECs in a large Finnish MCC sample cohort. Thus, the findings presented here suggest a molecular mechanism underlying an aggressive carcinoma with poor prognosis.
Merkel 细胞癌(MCC)是一种侵袭性皮肤癌,常由 Merkel 细胞多瘤病毒(MCPyV)引起。MCPyV 肿瘤(T)抗原的突变是病毒阳性(MCPyV+)MCC 的主要病理事件,但它们的来源尚不清楚。激活诱导的胞苷脱氨酶(AID)/APOBEC 家族胞苷脱氨酶通过突变病毒基因组有助于抗病毒免疫,是潜在的致癌突变剂。我们研究了 AID/APOBEC 胞苷脱氨酶对 MCPyV 大 T(LT)截短事件的贡献。MCC 中的 MCPyV 区域富含靶向胞嘧啶的突变,并且在 MCC 序列中观察到强烈的 APOBEC3 突变特征。在芬兰 MCC 样本队列中检测到 和 的表达,并且 表达与 和 相关。在 MCPyV 调节区检测到针对边缘化但具有统计学意义的体细胞超突变靶向活性。我们的结果表明,APOBEC3 胞苷脱氨酶可能是 MCPyV+MCC 中 LT 截断突变的合理原因,而 AID 在 MCC 癌变中的作用不太可能。
我们在 MCPyV 中揭示了 APOBEC3 突变特征,揭示了导致 MCPyV+MCC 突变的潜在原因。我们进一步揭示了 APOBEC 在大型芬兰 MCC 样本队列中的表达模式。因此,这里提出的发现提出了一种具有不良预后的侵袭性癌的分子机制。